| [1] |
陈明泉，李谦，张琼华, 等. 舒肝宁注射液治疗急慢性病毒性肝炎的临床疗效观察[J]. 肝脏,2007,12(3):194-196.
|
| [2] |
张瑾. 舒肝宁注射液对顺铂中毒小鼠肝脏损伤的保护作用[J]. 中国药房,2016,27(7):920-922.
|
| [3] |
潘婷，张金娟，熊英, 等. 舒肝宁注射液对大鼠酒精性肝纤维化的防治作用研究[J]. 中国药房,2017,28(19):2624-2627.
|
| [4] |
赵璐，曾南，刘晓帅, 等. 舒肝宁注射液对小鼠实验性肝损伤的保护作用[J]. 中药药理与临床,2007,23(6):65-67.
|
| [5] |
伍慧丽，谭永康，马列清, 等. 复方甘草酸苷联合舒肝宁注射液治疗病毒性肝炎疗效观察[J]. 中国中医药信息杂志,2009,16(6):72-73.
|
| [6] |
刘川贵，石海. 舒肝宁,肝得健治疗肝功能损害疗效对比[J]. 安徽医药,2009,13(2):198-199.
|
| [7] |
赵培东. 舒肝宁与复方甘草酸苷配伍治疗急性黄疸型病毒性肝炎162例[J]. 陕西医学杂志,2010,39(9):1196-1197.
|
| [8] |
台杰，刘峰，杨潇然, 等. 舒肝宁注射液治疗急性黄疸型肝炎45例临床分析[J]. 临床内科杂志,2007,24(2):103.
|
| [9] |
王小红，程玉娥，王煜. 舒肝宁联合异甘草酸镁治疗急性黄疸型肝炎临床疗效观察[J]. 现代医药卫生,2011,27(24):3774-3775.
|
| [10] |
韦秋玲. 加用舒肝宁注射液治疗急性黄疸型甲型肝炎72例[J]. 广西中医药,2010,33(5):31-32.
|
| [11] |
张斌，赵巍，王立蓉. 舒肝宁注射液对慢性乙型病毒性肝炎高胆红素血症患者肝功能及胆红素的影响[J]. 中医药导报,2014,20(16):71-73.
|
| [12] |
肖志鸿，欧阳丽娟，阮清发. 舒肝宁注射液治疗慢性乙肝黄疸40例[J]. 福建中医药,2009,40(2):15-16.
|
| [13] |
丘其春，曾伟强，邓媛芳. 舒肝宁联合复方甘草酸苷治疗慢性重度乙型肝炎的疗效观察[J]. 现代诊断与治疗,2019,30(12):2063-2065.
|
| [14] |
陈秀清，曹海芳. 恩替卡韦联合舒肝宁治疗慢性乙型肝炎高胆红素血症的临床观察[J]. 中成药,2018,41(9):2110-2112.
|
| [15] |
李娟，袁作辉，魏小果, 等. 舒肝宁注射液联合熊去氧胆酸治疗淤胆型肝炎50例[J]. 西部中医药,2016,29(6):90-91.
|
| [16] |
杨永俊. 优思弗联合舒肝宁注射液治疗重症淤胆性肝炎的效果分析[J]. 肝脏,2014,16(10):800-801.
|
| [17] |
程丹，刘文涛，黄新造. 熊去氧胆酸和舒肝宁注射液治疗重症淤胆性肝炎的临床观察[J]. 湖北中医杂志,2012,34(11):10-12.
|
| [18] |
魏阳，姚文秀，周行, 等. 舒肝宁治疗化疗药物所致肝损伤的临床疗效观察[J/CD]. 中国肝脏病杂志(电子版),2010,2(2):9-11.
|
| [19] |
中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南[J]. 中华肝脏病杂志,2015,23(11):810-827.
|
| [20] |
王凯，张百红，陈龙, 等. 舒肝宁注射液治疗晚期胃癌患者DCF方案治疗所致药物性肝损伤临床疗效观察[J]. 陕西中医,2016,37(2):133-134.
|
| [21] |
郑楠. 舒肝宁注射液用于治疗抗结核药物性肝损伤的临床效果[J]. 中国药物经济学,2017,12(11):43-45.
|
| [22] |
潘永峰. 舒肝宁联合还原型谷胱苷肽治疗药物性肝炎的临床疗效分析[J]. 实用肝脏病杂志,2009,12(4): 281-283.
|
| [23] |
傅念，阳学风，孟令引, 等. 舒肝宁注射液治疗酒精性与非酒精性脂肪肝疗效观察[J]. 中南医学科学杂志,2011,39(2):180-182.
|
| [24] |
王健. 舒肝宁联合腺苷蛋氨酸治疗肝硬化黄疸的疗效及安全性分析[J]. 临床合理用药杂志,2018,11(28):75-76.
|
| [25] |
胡振斌，王凯萌，姚凡, 等. 前列地尔联合舒肝宁治疗慢性肝衰竭疗效观察[J]. 中西医结合肝病杂志,2015,25(2):88-89, 105.
|
| [26] |
周文策，张全保，李汛, 等. 梗阻性黄疸术后应用舒肝宁注射液临床疗效观察[J/CD]. 中国肝脏病杂志(电子版),2010,2(1):22-25.
|
| [27] |
秦禄武，何龙海. 三镜联合术联合静脉注射舒肝宁治疗梗阻性化脓性胆管炎46例[J]. 安徽医药,2016,20(9):1763-1766.
|
| [28] |
杨学芳，李琳婵，王文辉. 舒肝宁联合还原型谷胱甘肽治疗肝癌TACE术后肝损害的临床观察[J]. 现代中西医结合杂志,2016,25(9):971-973.
|
| [29] |
杨峰，高学坤，朱松, 等. 某院舒肝宁注射液临床使用情况及合理性评价[J]. 安徽医药,2017,21(11):2100-2102.
|
| [30] |
Naveed M, Hejazi V, Abbas M, et al. Chlorogenic acid (CGA): A pharmacological review and call for further research[J]. Biomed Pharmacother,2018,97:67-74.
|
| [31] |
Bhandarkar NS, Brown L, Panchal SK. Chlorogenic acid attenuates high-carbohydrate, high-fat diet-induced cardiovascular, liver, and metabolic changes in rats[J]. Nutr Res,2019,62:78-88.
|
| [32] |
Tan Z, Luo M, Yang J, et al. Chlorogenic acid inhibits cholestatic liver injury induced by α-naphthylisothiocyanate: involvement of STAT3 and NFκB signalling regulation[J]. J Pharm Pharmacol,2016,68(9):1203-1213.
|
| [33] |
Shi H, Dong L, Jiang J, et al. Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway[J]. Toxicology,2013,303:107-114.
|
| [34] |
Yang S, Kuang G, Jiang R, et al. Geniposide protected hepatocytes from acetaminophen hepatotoxicity by down-regulating CYP 2E1 expression and inhibiting TLR 4/NF-κB signaling pathway[J]. Int Immunopharmacol,2019,74:105625.
|
| [35] |
Wang J, Miao M, Qu L, et al. Protective effects of geniposide against Tripterygium glycosides (TG)-induced liver injury and its mechanisms[J]. J Toxicol Sci,2016,41(1):165-173.
|
| [36] |
Wei J, Man Q, Ding C, et al. Proteomic investigations of transcription factors critical in geniposide-mediated suppression of alcoholic steatosis and in overdose-induced hepatotoxicity on liver in rats[J]. J Proteome Res,2019,18(11):3821-3830.
|
| [37] |
Shi L, Hao Z, Zhang S, et al. Baicalein and baicalin alleviate acetaminophen-induced liver injury by activating Nrf2 antioxidative pathway: The involvement of ERK1/2 and PKC[J]. Biochem Pharmacol,2018,150:9-23.
|
| [38] |
Huang Y, Sun M, Yang X, et al. Baicalin relieves inflammation stimulated by lipopolysaccharide via upregulating TUG1 in liver cells[J]. J Physiol Biochem,2019,75(4):463-473.
|
| [39] |
Wang H, Zhang Y, Bai R, et al. Baicalin attenuates alcoholic liver injury through modulation of hepatic oxidative stress, inflammation and sonic hedgehog pathway in rats[J]. Cell Physiol Biochem,2016,39(3):1129-1140.
|
| [40] |
潘以琳. 板蓝根有效提取物化学成分的研究及其不同产地的主成分分析[C]. 中国硕士学位论文全文数据库, 南京中医药大学, 2014年.
|
| [41] |
Qiu Z, Zhong D, Yang B. Preventive and therapeutic effect of Ganoderma (Lingzhi) on liver injury[J]. Adv Exp Med Biol, 2019,1182:217-242.
|
| [42] |
Chen YS, Chen QZ, Wang ZJ, et al. Anti-inflammatory and hepatoprotective effects of ganoderma lucidum polysaccharides against carbon tetrachloride-induced liver injury in Kunming mice[J]. Pharmacology,2019,103(3-4):143-150.
|
| [43] |
Hu Z, Du R, Xiu L, et al. Protective effect of triterpenes of Ganoderma lucidum on lipopolysaccharide-induced inflammatory responses and acute liver injury[J]. Cytokine,2020,127:154917.
|
| [44] |
Liu Y, Feng Y, Li YX, et al. Chlorogenic acid decreases malignant characteristics of hepatocellular carcinoma cells by inhibiting DNMT1 expression[J]. Front Pharmacol,2020,11:867.
|
| [45] |
Yu Y, Qian L, Du N, et al. Ganoderma lucidum polysaccharide enhances radiosensitivity of hepatocellular carcinoma cell line HepG2 through Akt signaling pathway[J]. Exp Ther Med,2017,14(6):5903-5907.
|